ADMA in the 13F filings
Adma Biologics Inc · CUSIP 000899104
- Quarter end
- 31 Dec 2024
- the date the book describes
- Filed
- 14 Feb 2025
- latest of these filings; the earliest 12 Feb 2025
- Managers listing it
- 7
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q3 2024 and Q4 2024; 6 listed it in both
- Shares listed
- 12,191,959
- combined, among listed positions
- Reported value
- $209m
- combined, at the quarter end
Among the 94 comparable managers: 3 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing ADMA in Q4 2024
7 of 7 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 3,769,888 | $65m | 0.10% | Added | +102,692 | 13 Feb 2025 (the filing on sec.gov) |
| Two Sigma Advisers LP | 2,950,124 | $51m | 0.12% | Trimmed | -1,504,276 | 14 Feb 2025 (the filing on sec.gov) |
| Arrowstreet Capital LP | 2,762,700 | $47m | under 0.1% | Added | +1,013,456 | 12 Feb 2025 (the filing on sec.gov) |
| Two Sigma Investments LP | 2,548,954 | $44m | 0.10% | Trimmed | -1,042,421 | 14 Feb 2025 (the filing on sec.gov) |
| Winton Group Ltd | 63,909 | $1.1m | 0.07% | Added | +9,573 | 12 Feb 2025 (the filing on sec.gov) |
| Caxton Associates LLP | 51,568 | $884k | under 0.1% | Trimmed | -24,280 | 14 Feb 2025 (the filing on sec.gov) |
| Freestone Grove Partners LP | 44,816 | $769k | under 0.1% | Held | n.a. | 14 Feb 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Arrowstreet Capital LPexisting position · 2,762,700 shares now+1,013,456
- Renaissance Technologies LLCexisting position · 3,769,888 shares now+102,692
- Winton Group Ltdexisting position · 63,909 shares now+9,573
Reductions
- Two Sigma Advisers LPexisting position · 2,950,124 shares now-1,504,276
- Two Sigma Investments LPexisting position · 2,548,954 shares now-1,042,421
- Caxton Associates LLPexisting position · 51,568 shares now-24,280
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2019 | 1 | $8.4m | n.a. | n.a. |
| Q3 2019 | 1 | $7.0m | n.a. | n.a. |
| Q4 2019 | 1 | $5.0m | n.a. | n.a. |
| Q1 2020 | 1 | $2.1m | n.a. | n.a. |
| Q2 2020 | 2 | $2.4m | n.a. | n.a. |
| Q3 2020 | 2 | $6.2m | n.a. | n.a. |
| Q1 2022 | 1 | $4.2m | n.a. | n.a. |
| Q2 2022 | 1 | $4.3m | n.a. | n.a. |
| Q3 2022 | 1 | $4.9m | n.a. | n.a. |
| Q4 2022 | 2 | $7.4m | n.a. | n.a. |
| Q1 2023 | 1 | $678k | n.a. | n.a. |
| Q2 2023 | 2 | $11m | n.a. | n.a. |
| Q3 2023 | 1 | $11m | n.a. | n.a. |
| Q4 2023 | 2 | $13m | 1 | 1 |
| Q1 2024 | 4 | $62m | 4 | 0 |
| Q2 2024 | 6 | $225m | 5 | 1 |
| Q3 2024 | 8 | $378m | 4 | 4 |
| Q4 2024 | 7 | $209m | 3 | 3 |
| Q1 2025 | 7 | $187m | 3 | 4 |
| Q2 2025 | 6 | $88m | 3 | 2 |
| Q3 2025 | 4 | $221m | 2 | 3 |
| Q4 2025 | 8 | $464m | 16 | 17 |
| Q1 2026 | 3 | $106m | 22 | 9 |
| Q2 2026 | 1 | $73m | 10 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ADMA and GILD →ADMA and AMGN →ADMA and ARGX →Choose a stock to compare with ADMA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ADMA, latest filings →Back to the 13F Explorer →